10-Q quarterly report · filed Apr 29, 2026

Cognizant (CTSH) Q1 2026 10-Q Quarterly Report

Short answer

Cognizant (CTSH) filed its Q1 2026 10-Q quarterly report on Apr 29, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $5.4B (up 5.8% year over year) with net income of $662M.

Q1 2026 key financials · XBRL

Revenue
$5.4B
+5.8% YoY
Net income
$662M
−0.2% YoY
Operating margin
15.6%
EPS (diluted)
$1.39
+3.7% YoY

Source: XBRL data from the Cognizant (CTSH) Q1 2026 10-Q on SEC EDGAR. USD.

Cognizant Q1 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Revenue $5,413M, up $298M or 5.8% YoY, with constant-currency growth of 3.9%
  • GAAP operating margin 15.6% vs 16.7% YoY; adjusted margin 15.6% vs 15.5%
  • Best segment Financial Services, revenue up $182M or 12.4%; weakest Health Sciences, up $8M or 0.5%
  • Cash $1,517M; operating cash flow $274M vs $400M YoY, while investing outflows reached $806M after the 3Cloud acquisition
  • Project Leap costs $230M–$320M in 2026, targeting in-year savings of $200M–$300M amid macroeconomic, tariff and AI-disruption risks

Risk Factors

  • New Project Leap risk, triggered by Q2 2026 launch and associated headcount reductions
  • Operational disruption risk, including institutional-knowledge loss and employee retention challenges
  • Cost-overrun risk, with projected Project Leap charges of $230 million to $320 million
  • Regulatory compliance risk, with position eliminations subject to local laws and consultation requirements
  • Financial risk, with $1.491 billion remaining under the stock-repurchase authorization as of March 31, 2026

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other Cognizant quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.